Agent skill
armored-cart-design-agent
Install this agent skill to your Project
npx add-skill https://github.com/FreedomIntelligence/OpenClaw-Medical-Skills/tree/main/skills/armored-cart-design-agent
SKILL.md
name: 'armored-cart-design-agent' description: 'AI-powered design of armored CAR-T cells with cytokine/chemokine expression for enhanced solid tumor efficacy, including IL-12, IL-15, IL-18, and IL-7 armoring strategies.' measurable_outcome: Execute skill workflow successfully with valid output within 15 minutes. allowed-tools:
- read_file
- run_shell_command
Armored CAR-T Design Agent
The Armored CAR-T Design Agent provides AI-assisted design of next-generation armored CAR-T cells engineered to express cytokines, chemokines, or other enhancing factors. These armored T cells overcome solid tumor challenges including immunosuppressive TME, poor trafficking, and T cell exhaustion, with recent clinical success in lymphoma (IL-18) and ongoing trials with IL-12, IL-15, and IL-7.
When to Use This Skill
- When designing CAR-T cells for solid tumor applications.
- For selecting optimal armoring payloads (cytokines, chemokines).
- To optimize cytokine expression levels and regulation.
- When engineering safety switches for armored constructs.
- For predicting armored CAR-T efficacy and safety profiles.
Core Capabilities
-
Armoring Payload Selection: Choose optimal cytokines for tumor type.
-
Expression Level Optimization: Balance efficacy vs toxicity.
-
Inducible System Design: Engineer regulated expression systems.
-
Safety Switch Integration: Design kill switches and controls.
-
Construct Optimization: Optimize transgene configuration.
-
Efficacy Prediction: Predict enhanced tumor killing.
Armoring Strategies
| Cytokine | Mechanism | Clinical Status | Tumor Types |
|---|---|---|---|
| IL-12 | Th1 polarization, IFN-gamma | Phase I/II | Solid tumors |
| IL-15 | T/NK persistence | Phase I/II | Hematologic, solid |
| IL-18 | Inflammasome, IFN-gamma | Phase I (promising) | Lymphoma |
| IL-7 | T cell survival | Phase I | Multiple |
| IL-21 | T cell proliferation | Preclinical | Multiple |
| CCL19/21 | T cell trafficking | Preclinical | Solid tumors |
Construct Architecture Options
| Component | Options | Consideration |
|---|---|---|
| Promoter | EF1a, PGK, CAG, NFAT-inducible | Expression level/timing |
| Signal Peptide | Native, IL-2ss, IgK | Secretion efficiency |
| Cytokine | Membrane-bound vs secreted | Local vs systemic |
| Linker | T2A, P2A, IRES | Co-expression efficiency |
| Kill Switch | iCasp9, HSV-TK, CD20 | Safety control |
| Position | Before/after CAR | Expression balance |
Workflow
-
Input: Target tumor type, TME characteristics, CAR design.
-
Payload Selection: Rank armoring strategies for tumor context.
-
Expression Design: Optimize promoter, levels, regulation.
-
Safety Engineering: Add appropriate control switches.
-
Construct Assembly: Generate optimized DNA sequence.
-
Efficacy Prediction: Model enhanced killing and persistence.
-
Output: Optimized armored CAR construct with annotations.
Example Usage
User: "Design an armored CAR-T for pancreatic cancer targeting mesothelin with IL-12 armoring for TME remodeling."
Agent Action:
python3 Skills/Immunology_Vaccines/Armored_CART_Design_Agent/design_armored_cart.py \
--car_target mesothelin \
--tumor_type pancreatic \
--armoring_payload IL-12 \
--expression_system NFAT_inducible \
--safety_switch iCasp9 \
--backbone lentiviral \
--optimize_codon human \
--output armored_cart_design/
Output Components
| Output | Description | Format |
|---|---|---|
| Construct Sequence | Full transgene DNA | .fasta, .gb |
| Construct Map | Annotated visualization | .png, .pdf |
| Expression Model | Predicted levels | .json |
| Safety Analysis | Risk assessment | .json |
| Manufacturing Guide | Production recommendations | .md |
| Predicted Efficacy | Tumor killing model | .json |
IL-12 Armoring Details
| Aspect | Design Choice | Rationale |
|---|---|---|
| Configuration | Tethered IL-12 (p70) | Localized, reduced toxicity |
| Expression | NFAT-inducible | Activation-dependent |
| Dose | Low-level expression | Safety optimization |
| Combination | With PD-1 knockout | Enhanced activity |
IL-18 Armoring Details
| Aspect | Design Choice | Rationale |
|---|---|---|
| Configuration | Secreted mature IL-18 | Enhanced IFN-gamma |
| Expression | Constitutive or inducible | Context-dependent |
| Clinical Results | Lymphoma responses | Validated approach |
| Combination | With IL-21 | Synergistic |
IL-15 Armoring Details
| Aspect | Design Choice | Rationale |
|---|---|---|
| Configuration | Membrane-tethered IL-15/IL-15Ra | Cis-presentation |
| Expression | Constitutive moderate | Persistence without toxicity |
| Benefit | Reduced IL-2 dependence | Manufacturing advantage |
| Safety | Lower CRS risk | Clinical benefit |
AI/ML Components
Payload Selection:
- TME profiling to match cytokine needs
- Multi-objective optimization
- Clinical outcome modeling
Expression Optimization:
- Promoter strength prediction
- Codon optimization
- mRNA stability modeling
Safety Prediction:
- CRS/ICANS risk modeling
- Off-tumor activity prediction
- Systemic cytokine levels
Safety Considerations
| Risk | Mitigation | Implementation |
|---|---|---|
| Cytokine storm | Inducible expression | NFAT promoter |
| Systemic toxicity | Membrane tethering | Localized effect |
| Uncontrolled proliferation | Kill switch | iCasp9 |
| On-target off-tumor | Regulatable CAR | Logic gates |
Clinical Trials (2025-2026)
| Trial | Armoring | Target | Cancer | Status |
|---|---|---|---|---|
| NCT03721068 | IL-18 | CD19 | Lymphoma | Phase I (positive) |
| NCT04119024 | IL-12 | GD2 | Neuroblastoma | Phase I |
| NCT03932565 | IL-15/21 | CD19 | B-ALL | Phase I |
| Multiple | IL-7/CCL19 | Various | Solid | Preclinical |
Prerequisites
- Python 3.10+
- Biopython for sequence handling
- CAR design databases
- Codon optimization tools
- Structure prediction (optional)
Related Skills
- CART_Design_Optimizer_Agent - Base CAR optimization
- NK_Cell_Therapy_Agent - NK cell engineering
- Cytokine_Storm_Analysis_Agent - Safety analysis
- TCell_Exhaustion_Analysis_Agent - Exhaustion prevention
Manufacturing Considerations
| Aspect | Armored CAR Challenge | Solution |
|---|---|---|
| Vector Size | Larger transgene | Optimize construct |
| Transduction | Lower efficiency | Increase MOI |
| Expansion | Cytokine effects | Tune expression |
| Characterization | Complex phenotype | Enhanced QC |
Special Considerations
- Tumor Type Matching: Different tumors need different armoring
- Expression Timing: Constitutive vs inducible tradeoffs
- Dose Finding: Balance efficacy vs toxicity
- Combination: Consider with checkpoint knockout
- Manufacturing: Larger constructs affect production
Efficacy Enhancement Mechanisms
| Mechanism | Cytokine | Effect |
|---|---|---|
| Persistence | IL-15, IL-7 | Longer survival |
| TME Remodeling | IL-12 | M2→M1, DC activation |
| Bystander Killing | IL-18 | Enhanced IFN-gamma |
| Trafficking | CCL19/21 | T cell recruitment |
| Anti-exhaustion | IL-21 | Stem-like maintenance |
Author
AI Group - Biomedical AI Platform
Recommended Agent Skills
Expand your agent's capabilities with these related and highly-rated skills.
vcf-annotator
Annotate VCF variants with VEP, ClinVar, gnomAD frequencies, and ancestry-aware context. Generates prioritised variant reports.
chemist-analyst
Analyzes events through chemistry lens using molecular structure, reaction mechanisms, thermodynamics, kinetics, and analytical techniques (spectroscopy, chromatography, mass spectrometry). Provides insights on chemical processes, material properties, reaction pathways, synthesis, and analytical methods. Use when: Chemical reactions, material analysis, synthesis planning, process optimization, environmental chemistry. Evaluates: Molecular structure, reaction mechanisms, yield, selectivity, safety, environmental impact.
bio-alignment-io
Read, write, and convert multiple sequence alignment files using Biopython Bio.AlignIO. Supports Clustal, PHYLIP, Stockholm, FASTA, Nexus, and other alignment formats for phylogenetics and conservation analysis. Use when reading, writing, or converting alignment file formats.
sleep-analyzer
分析睡眠数据、识别睡眠模式、评估睡眠质量,并提供个性化睡眠改善建议。支持与其他健康数据的关联分析。
metabolomics-workbench-database
Access NIH Metabolomics Workbench via REST API (4,200+ studies). Query metabolites, RefMet nomenclature, MS/NMR data, m/z searches, study metadata, for metabolomics and biomarker discovery.
bio-hi-c-analysis-matrix-operations
Balance, normalize, and transform Hi-C contact matrices using cooler and cooltools. Apply iterative correction (ICE), compute expected values, and generate observed/expected matrices. Use when normalizing or transforming Hi-C matrices.
Didn't find tool you were looking for?